INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on June 22, 2026, by INVO Fertility, Inc., a Nevada corporation listed on The Nasdaq Stock Market LLC. The filing serves to announce the financial results for the quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release (Exhibit 99.1), which is not included in the source text.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The document acts solely as a notification that results for the quarter ended March 31, 2026, have been issued.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated June 22, 2026) for actual financial figures.
- Verify the specific revenue and net income figures for the quarter ended March 31, 2026.
- Check for any forward-looking statements or updated guidance in the full press release.
- Confirm the status of the company's cash position and liquidity as detailed in the full report.